FHI 360

Story Map: Workforce

FHI 360 projects build a strong and resilient workforce to meet evolving economic demands.

View Interactive Map

Deeper Look

CEO Patrick Fine talks with Vikki Spruill of the Council on Foundations about the impact of philanthropy on the SDGs.

Listen to the podcast

Global Handwashing Day

An FHI 360 expert discusses evidence on what drives behavior change for handwashing.

Read The Blog

Eliminating Tuberculosis

FHI 360 will share its response to the TB epidemic at the 48th Union World Conference on Lung Health.

Learn More

International Day Of The Girl

FHI 360 uses a positive girl development approach to address the unique, multifaceted needs of adolescent girls.

Watch The Video

next prev

Solutions

The challenge of developing a clinical trial for an Ebola vaccine

October 9, 2017

Patricia Matuku inspects her thriving pearl millet crops.

Local classes show a mother in Kenya how to grow nutritious food for her family

October 2, 2017

Promising approaches to supporting students living in violent communities in El Salvador

September 19, 2017

Youth engagement — and empowerment — holds promise for strengthening community resilience to violent extremism

October 11, 2017

Preparing the future workforce requires transformations in what we know, how we learn and how we work

September 12, 2017

FROM THE CEO

Tracking media and measuring accountability for the SDGs

September 14, 2017

Congratulating the new head of UNFPA

October 04, 2017

FHI 360 is pleased to learn that Dr. Natalia Kanem has been appointed Executive Director of the United Nations Population Fund (UNFPA) and wishes her well in achieving the organization’s important vision.

Don't miss our latest published research list

September 28, 2017

Dr. Timothy Mastro, Chief Science Officer, describes his top three picks from the latest published research from FHI 360.

Listen

FHI 360's clinical trials expertise supports further development of a Zika virus vaccine

September 21, 2017

FHI 360 is providing monitoring services for a trial to evaluate a DNA vaccine for the Zika virus, which could protect healthy adults and adolescents.